Subscribe to RSS
DOI: 10.1055/s-2003-39798
Porcine endogene Retroviren (PERVs) und Xenotransplantation
Ein Risiko für Rezipient und Gesellschaft?Porcine endogenous retroviruses (PERVs) and xenotransplantationA risk for the recipient and for society?Publication History
eingereicht: 2.12.2002
akzeptiert: 27.2.2003
Publication Date:
05 June 2003 (online)

Die Xenotransplantation, d. h. die Transplantation von tierischen Zellen, Geweben und Organen auf den Menschen, stellt eine vielversprechende Möglichkeit dar, den Mangel an verfügbaren menschlichen Transplantaten zu überbrücken. Aus verschiedenen Gründen werden zur Zeit Schweine als potenzielle Spender von Xenotransplantaten favorisiert. Jedoch ist mit der Verwendung porciner Xenotransplantate das Risiko einer Übertragung von Mikroorganismen auf den humanen Rezipienten verbunden. Dabei geht das größte Risiko von den porcinen endogenen Retroviren (PERVs) aus, die in vielfachen Kopien im Genom aller Schweinerassen integriert sind und die humane Zellen in vitro infizieren. Die PERVs sind mit Retroviren verwand, von denen die meisten Tumore und Immundefizienzen im infizierten Wirt hervorrufen können. Es muss deshalb geprüft werden, ob die Transplantation porciner Organe auf den Menschen eine Übertragung dieser Viren mit sich bringt und damit ein Risiko für den Rezipienten und die Gesellschaft darstellen könnte.
Literatur
- 1
Blusch J H, Patience C, Takeuchi Y. et al .
Infection of nonhuman primate cells by pig endogenous
retrovirus.
J
Virol.
2000;
74
7687-7690
MissingFormLabel
- 2
Blusch J H, Patience C, Martin U.
Pig endogenous retroviruses and
xenotransplantation.
Xenotransplantation.
2002;
9
242-251
MissingFormLabel
- 3
Brenner P, Reichenspurner H, Schmoeckel M. et al .
Prevention of hyperacute xenograft rejection in orthotopic
xenotransplantation of pig hearts into baboons using immunoadsorption of
antibodies and complement factors.
Transpl
Int.
2000;
13
(Suppl
1)
508-517
MissingFormLabel
- 4
Byrne G W, McCurry K R, Martin M J, McClellan S M, Platt J L, Logan J S.
Transgenic pigs expressing human CD59 and decay-accelerating
factor produce an intrinsic barrier to complement-mediated
damage.
Transplantation.
1997;
63
149-155
MissingFormLabel
- 5
Clemenceau B, Jegou D, Sai P.
Microchimerism and transmission of porcine endogenous
retrovirus from a pig cell line or specific pathogen-free islets to mouse
tissues and human cells during xenografts in nude
mice.
Diabetologia.
2002;
45
914-923
MissingFormLabel
- 6
Deng Y M, Tuch B E, Rawlinson W D.
Transmission of porcine endogenous retroviruses in severe
combined immunodeficient mice xenotransplanted with fetal porcine pancreatic
cells.
Transplantation.
2000;
70
1010-1016
MissingFormLabel
- 7 Denner J. Immunosuppression by oncogenic
retroviridae. Jena: Gustav Fischer Verlag In:
Zschiesche W, editor. Immune modulation by infectious
agents 1987
MissingFormLabel
- 8
Denner J.
Immunosuppression by retroviruses: implications for
xenotrans-plantation.
Ann NY Acad
Sci.
1998;
862
75-86
MissingFormLabel
- 9
Denner J.
Immunsuppression durch Retroviren: Implikationen für die
Xenotransplantation.
Tx
Med.
1999;
11
223-233
MissingFormLabel
- 10 Denner J. Mikrobiologische Risiken der
Xenotransplantation. Baden-Baden: Nomos
Verlagsgesellschaft In: Engels EM, Badura-Lotter G, Schicktanz
S, editors. Neue Perspektive der Transplantationsmedizin im
interdisziplinären
Dialog 2000: 142-169
MissingFormLabel
- 11 Denner J. Xenotransplanation, Transspezies-Übertragung von
Retroviren und AIDS. München: Urban & Vogel Medien und
Medizin Verlagsgesellschaft In: Arndt D, Obe G, Kleeberg U,
editors. Biotechnologische Verfahren und Möglichkeiten in der
Medizin 2001: 164-183
MissingFormLabel
- 12
Denner J, Specke V, Tacke S, Özel M.
Porcine endogenous retroviruses (PERVs): Diagnostic assays,
adaptation to human cells and infection experiments with small animals and
non-human primates.
Tx
Med.
2002;
14
171-183
MissingFormLabel
- 13
Denner J, Specke V, Tacke S J, Boller K.
Porcine endogene Retroviren (PERVs): Erste Tiermodelle,
hochsensitive Diagnostika und immunsuppressive Eigenschaften.
Tx
Med.
2002;
14
231-245
MissingFormLabel
- 14
Denner J, Specke V, Schwendemann J, Tacke S J.
Porcine endogenous retroviruses (PERVs): Adaptation to human
cells and attempts to infect small animals and non-human
primates.
Ann
Transpl.
2001;
6
25-33
MissingFormLabel
- 15 Denner J, Tacke S, Specke V, Stephan O, Boller K, Schwendemann J. Entwicklung von Testsystemen zum Nachweis porciner endogener
Retroviren. Schattauer Verlag In: Grimm H,
editor. Xenotransplantation, Grundlagen - Chancen -
Risiken 2002: 259-279
MissingFormLabel
- 16
Elliott R B, Escobar L, Garkavenko O. et al .
No evidence of infection with porcine endogenous retroviruse
in recipients of encapsulated porcine islet xenografts.
Cell
Transspl.
2000;
9
895-901
MissingFormLabel
- 17
Fiebig U, Kurth R, Denner J.
Neutralizing antibodies against conserved domains of p15E of
porcine endogenous retroviruses (PERVs): Basis for a vaccine for
xenotransplantation?.
Virology.
in press
MissingFormLabel
- 18
Fink J S, Schumacher J M, Elias S L. et al .
Porcine xenografts in Parkinson`s disease and
Huntington`s disease patients: preliminary results.
Cell
Transplantation.
2000;
9
273-278
MissingFormLabel
- 19
Li S F, Neethling F A, Tangiguchi S. et al .
Glycans derived from porcine stomach mucin are effective
inhibitors of natural anti-alpha-galactosyl antibodies in vitro and after
intravenous infusion in
baboons.
Transplantation.
1996;
62
1324-1331
MissingFormLabel
- 20
Loss M, Arends H, Winkler M. et al .
Analysis of potential porcine endogenous retrovirus (PERV)
transmission in a whole-organ xenotransplantation model without interfering
microchimerism.
Transpl
Int.
2001;
14
31-37
MissingFormLabel
- 21
Martin U, Tacke S J, Simon A R. et al .
Absence of PERV specific humoral immune response in baboons
after transplantation of porcine cells or organs.
Transpl
Int.
2002;
15
361-368
MissingFormLabel
- 22
Martin U, Winkler M E, Id M. et al .
Productive infection of primary human endothelial cells by
pig endogenous retrovirus
(PERV).
Xenotransplantation.
2000;
7
138-142
MissingFormLabel
- 23
McKenzie I F, Xing P X, Vaughan H A, Prenzoska J, Dabkowski P L, Sandrin M S.
Distribution of the major xenoantigen (gal (alpha
1 - 3)gal) for pig to human xenografts.
Transpl
Immunol.
1994;
2
81-86
MissingFormLabel
- 24
Oldmixon B A, Wood J C, Ericsson T A. et al .
Porcine endogenous retrovirus transmission characteristics of
an inbred herd of miniature swine.
J
Virol.
2002;
76
3045-3048
MissingFormLabel
- 25
Osman N, McKenzie I F, Ostenried K, Ioannou Y A, Desnick R J, Sandrin M S.
Combined transgenic expression of alpha-galactosidase and
alpha-1,2-fucosyltransferase leads to optimal reduction in the major
xenoepitope Gal-alpha(1,3) Gal.
Proc Natl Acad Sci
USA.
1997;
94
14 677-14 682
MissingFormLabel
- 26
Paradis K, Langford G, Long Z. et al .
Search for cross-species transmission of porcine endogenous
retrovirus in patients treated with living pig
tissue.
Science.
1999;
285
1236-1241
MissingFormLabel
- 27
Patience C, Takeuchi Y, Weiss R A.
Infection of human cells by an endogenous retrovirus of
pig.
Nat
Med.
1997;
3
282-286
MissingFormLabel
- 28
Patience C, Patton G S, Takeuchi Y. et al .
No evidence of pig DNA or retroviral infection in patients
with short-term extracorporeal connection to pig
kidneys.
Lancet.
1998;
352
699-701
MissingFormLabel
- 29
Phelps C J, Koike C, Vaught T D. et al .
Production of alpha-1,3-galactosyltransferase-deficient
pigs.
Science.
2003;
299
411-414
MissingFormLabel
- 30
Pitkin Z, Mullon C.
Evidence of absence of porcine endogenous retrovirus (PERV)
infection in patients treated with a bioartificial liver support
system.
Artif
Org.
1999;
23
829-833
MissingFormLabel
- 31
Platt J L, Lin S S, McGregor C GA.
Acute vascular
rejection.
Xenotransplantation.
1998;
5
169-175
MissingFormLabel
- 32
Satake M, Kawagishi N, Moller E.
Direct activation of human responder T cells by porcine
stimulator cells leads to T cell proliferation and cytotoxic T cell
developement.
Xenotransplantation.
1996;
3
198-206
MissingFormLabel
- 33
Sauer M, Kardassis D, Zeillinger K. et al .
Extracorporeal hybrid liver support therapy - phase I
study with primary porcine liver
cells.
Xenotransplantation.
in press
MissingFormLabel
- 34
Scheef G, Fischer N, Krach U, Tönjes R R.
Number of U3 repeat box acting as an enhancer in long
terminal repeats of polytropic replication-competent porcine endogenous
retrovirus dynamically fluctuates during serial virus passages in human
cells.
J
Virol.
2001;
75
6933-6940
MissingFormLabel
- 35
Schmoeckel M, Nollert G, Shahmohammadi M. et al .
Transgenic human decay accelerating factor makes normal pigs
function as a concordant species.
J Heart Lung
Transplant.
1997;
16
758-764
MissingFormLabel
- 36
Shen J, Chong A SF, Xiao F. et al .
Histological characterization and pharmacological control of
chronic rejection in xenogenic and allogenic heart
transplantation.
Transplantation.
1998;
66
692-698
MissingFormLabel
- 37
Specke V, Tacke S J, Boller K, Schwendemann J, Denner J.
Porcine endogenous retroviruses (PERVs): In vitro host range
and attempts to establish small animal models.
J Gen
Virol.
2001;
82
837-844
MissingFormLabel
- 38
Specke V, Rubant S, Denner J.
Productive infection of human primary cells and cell lines
with porcine endogenous
retroviruses.
Virology.
2001;
285
177-180
MissingFormLabel
- 39
Specke V, Plesker R, Coulibaly C, Boller K, Denner J.
Productive infection of a mink cell line with porcine
endogenous retroviruses (PERVs) but lack of transmission in
vivo.
Arch
Virol.
2002;
147
305-319
MissingFormLabel
- 40
Specke V, Schuurman H J, Plesker R. et al .
Virus safety in xenotransplantation: first exploratory in
vivo studies in small laboratory animals and non-human
primates.
Transpl
Immunol.
2002;
9
281-288
MissingFormLabel
- 41
Switzer W M, Michler R E, Shanmugam V. et al .
Lack of cross-species transmission of porcine endogenous
retrovirus infection to nonhuman primate recipients of porcine cells, tissues,
or
organs.
Transplantation.
2001;
71
959-965
MissingFormLabel
- 42
Tacke S J, Kurth R, Denner J.
Porcine endogenous retrovirus inhibit human immune cell
funktions: Risk for
xenotransplantation.
Virology.
2000;
268
87-93
MissingFormLabel
- 43
Tacke S, Bodusch K, Berg A, Denner J.
Sensitive and specific detection methods for porcine
endogenous retroviruses applicable to experimental and clinical
xenotransplantation.
Xenotransplantation.
2001;
8
125-135
MissingFormLabel
- 44
Tacke S J, Specke V, Denner J.
Differences in release and determination of subtype of
porcine endogenous retroviruses (PERV) produced by stimulated normal pig blood
cells.
Intervirology.
2003;
46
17-24
MissingFormLabel
- 45
Takefman D M, Wong S, Maudru T, Peden K, Wilson C A.
Detection and characterization of porcine endogenous
retrovirus in porcine plasma and porcine factor VIII.
J
Virol.
2001;
75
4551-4557
MissingFormLabel
- 46
Takeuchi Y, Cosset F L, Lachmann P J, Okada H, Weiss R A, Collins M K.
Type C retroviruse inactivation by human complement is
determined by both the viral genome and the producer cell.
J
Virol.
1994;
68
8001
MissingFormLabel
- 47
Takeuchi Y, Patience C, Magre S. et al .
Host range and interference studies of three classes of pig
endogenous retrovirus.
J
Virol.
1998;
72
9986-9991
MissingFormLabel
- 48
Van der Laan L JW, Lockey C, Griffeth B C. et al .
Infection by porcine endogenous retrovirus after
xenotransplantation in SCID
mice.
Nature.
2000;
407
90-94
MissingFormLabel
- 49
Wilson C A, Wong S, Muller J, Davidson C E, Rose T M, Burd P.
Type C retrovirus released from porcine primary peripheral
blood mononuclear cells infects human cells.
J
Virol.
1998;
72
3082-3087
MissingFormLabel
- 50
Wilson C A, Wong S, VanBrocklin M, Federspiel M J.
Extended analysis of the in vitro tropism of porcine
endogenous retrovirus.
J
Virol.
2000;
74
49-56
MissingFormLabel
Dr. Joachim Denner
Robert Koch-Institut
Nordufer 20
13353 Berlin
Phone: +49/030/45472800
Fax: +49/030/45472801
Email: DennerJ@rki.de